Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
NVCR
#1845
NovoCure Limited Ordinary Shares
13.670
0
+2.78%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+2.78%
Changement Mensuel
+4.75%
Evolution sur 6 mois
-0.58%
Changement Annuel
-0.58%
Clôture Précédente
13.300
0
Open
13.670
0
Bid
Ask
Low
13.670
0
High
13.670
0
Volume
177
Marchés
Actions des Marchés US
Soins de Santé
NVCR
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
102.41 M
104.42 M
105.46 M
107.09 M
109.92 M
113.79 M
—
Valuation ratios
Enterprise value
17.49 B
7.63 B
7.05 B
1.3 B
3.11 B
1.38 B
6.18 B
Price to earnings ratio
961.33
-134.07
-77.2
-7.38
-19.1
-10.6
-41.83
Price to sales ratio
38.11
14.51
13.22
3.01
5.31
—
—
Price to cash flow ratio
190.02
93.84
230.95
-20.89
-121.87
29.4
-57.48
Price to book ratio
39.54
18.92
16.12
4.23
8.92
4.23
7.93
Enterprise value to EBITDA ratio
465.69
-199.86
-84.8
-5.77
-19.24
—
—
Profitability ratios
Return on assets %
0.02
0.05
0.08
0.18
0.14
0.17
0.12
Return on equity %
0.04
0.14
0.21
0.57
0.47
0.4
0.39
Return on invested capital %
126.89
190.67
412.41
824.83
200.54
132.06
110.67
Gross margin %
78.46
78.53
78.64
74.81
77.33
74.54
298.1
Operating margin %
6.15
8.29
16.64
45.72
28.17
23.47
94.03
EBITDA margin %
7.6
-7.14
-15.46
-44.3
-26.72
-21.48
-79.69
Net margin %
4.01
10.91
17.2
40.65
27.86
20.79
83.76
Liquidity ratios
Quick ratio
8.56
7.36
6.82
5.56
1.42
2.71
7.01
Current ratio
8.8
7.53
7
5.78
1.46
2.9
7.35
Inventory turnover
0.02
0.04
0.01
0
0.01
0.08
—
Asset turnover
0.65
0.49
0.46
0.44
0.51
0.64
0.54
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.41
0.49
0.47
0.5
0.08
0.24
0.54
Long term debt to total equity ratio
0.9
1.37
1.28
1.57
0.27
0.57
1.69
Per share metrics
Operating cash flow per share
0.91
0.8
0.29
0.69
0.24
0.44
0.44
EBIT per share
0.28
-0.43
-0.86
-2.19
-1.58
-1.38
-1.38
EBITDA per share
0.34
-0.37
-0.79
-2.12
-1.5
-1.26
-1.17
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.74
9.07
9.26
8.56
8.9
4.02
29.85
Net current asset value per share
9.18
10.38
10.62
9.72
10.26
5.8
36.11
Tangible book value per share
4.38
3.97
4.22
3.41
3.34
3.05
12.52
Working capital per share
8.14
9
9.1
8.04
3.25
3.8
13.71
Book value per share
4.38
3.97
4.22
3.41
3.34
3.05
12.52
Nouvelles
NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates
NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript
Novocure Ltd earnings beat by $0.19, revenue topped estimates
Netflix and Palantir among market cap stock movers on Wednesday
Résultats Novocure à venir : lancement du traitement du cancer du pancréas au centre de l’attention
Novocure earnings up next: Pancreatic cancer launch in focus
Oracle and Netflix among market cap stock movers on Wednesday
L’action Novocure bondit après le rétablissement de la facturation Medicare
Novocure stock jumps after Medicare billing restored
Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
NovoCure: FDA Approval For PC Unlocked With TTFields Expansion Opportunity Approaching